{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:39:43Z","timestamp":1793281183875,"version":"4.5.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41573-026-01537-w","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:02:03Z","timestamp":1789977723000},"page":"895-896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two trials or not two trials? That should not be the question"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6640-0117","authenticated-orcid":false,"given":"Peter","family":"Arlett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Thirstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Garcia","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacho","family":"Mbaeliachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Foggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Roes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emer","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-0955","authenticated-orcid":false,"given":"Bruno","family":"Sepodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"1537_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrd4621","volume":"14","author":"M Hofer","year":"2015","unstructured":"Hofer, M. P. et al. Impact of scientific advice from the European Medicines Agency. Nat. Rev. Drug Discov. 14, 302\u2013303 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1537_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJMsb2517623","volume":"394","author":"V Prasad","year":"2026","unstructured":"Prasad, V. & Makary, M. A. One pivotal trial, the new default option for FDA approval \u2014 ending the two-trial dogma. N. Engl. J. Med. 394, 815\u2013817 (2026).","journal-title":"N. Engl. J. Med."},{"key":"1537_CR3","unstructured":"US Food and Drug Administration. Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products. Draft Guidance. https:\/\/www.fda.gov\/media\/133660\/download (2026)."},{"key":"1537_CR4","unstructured":"European Medicines Agency. Points to consider on application with 1. meta-analyses; 2. one pivotal study. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/points-consider-application-1meta-analyses-2one-pivotal-study_en.pdf (2001)."},{"key":"1537_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s44161-024-00420-4","volume":"3","author":"HGC Van Spall","year":"2024","unstructured":"Van Spall, H. G. C. et al. The role of early-phase trials and real-world evidence in drug development. Nat. Cardiovasc. Res. 3, 110\u2013117 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1537_CR6","unstructured":"European Medicines Agency. Assessment report. Opdivo. Procedure no. EMEA\/H\/C\/003985\/0000. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/opdivo-epar-public-assessment-report_en.pdf (2015)."},{"key":"1537_CR7","unstructured":"European Medicines Agency. Assessment report. Keytruda. Procedure No. EMEA\/H\/C\/003820\/0000. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/keytruda-epar-public-assessment-report_en.pdf (2015)."},{"key":"1537_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/cpt.3596","volume":"117","author":"P Arlett","year":"2025","unstructured":"Arlett, P. et al. Clinical evidence 2030. Clin. Pharmacol. Ther. 117, 884\u2013886 (2025).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1537_CR9","doi-asserted-by":"publisher","first-page":"e2415445","DOI":"10.1001\/jamanetworkopen.2024.15445","volume":"7","author":"A Sertkaya","year":"2024","unstructured":"Sertkaya, A., Beleche, T., Jessup, A. & Sommers, B. D. Costs of drug development and research and development intensity in the US, 2000-2018. JAMA Netw. Open. 7, e2415445 (2024).","journal-title":"JAMA Netw. Open."},{"key":"1537_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00228-009-0756-y","volume":"66","author":"J Regnstrom","year":"2010","unstructured":"Regnstrom, J. et al. Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency. Eur. J. Clin. Pharmacol. 66, 39\u201348 (2010).","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01537-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01537-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01537-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:02:29Z","timestamp":1793278949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01537-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1537"],"URL":"https:\/\/doi.org\/10.1038\/s41573-026-01537-w","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"21 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}